Tazarotene 0.045% Lotion: A Leap Forward in Acne and Oiliness Treatment
Hey fam! In this edition, we will explore the dual action of Tazarotene 0.045% lotion.
This research paper was published in January 2023 in Journal of Dermatological Treatment.
Title- Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin.
Emil A. Tanghetti, Joshua A. Zeichner, Michael Gold, Neil Sadick, Fran E. Cook-Bolden, Leon H. Kircik, Linda Stein Gold, Jonathan Weiss, Stephen K. Tyring, James Q. Del Rosso & Eric Guenin
First Published- 23 January 2023
DOI- 10.1080/09546634.2022.2147391
Tazarotene 0.045%, is a retinoid that not only targets acne but also addresses the persistent challenge of oily skin, a root cause of acne vulgaris. In this article, we delve into the results of clinical studies and explore how this formulation can be leveraged for treatment of acne.
Tazarotene acts primarily by normalizing keratinization, reducing inflammation, and promoting collagen synthesis in the skin. It improves conditions like acne, psoriasis, and photoaging by regulating skin cell turnover, suppressing pro-inflammatory factors, and enhancing collagen production, ultimately leading to smoother, clearer, and healthier skin.
- Clinical Studies and Acne Reduction
Tazarotene 0.045% lotion underwent rigorous evaluation in two phase 3 clinical trials. The results were promising and transformative as follows:
- Acne Lesion Reduction: Participants experienced 55% reduction in both inflammatory and noninflammatory acne lesions. This reduction significantly improved overall skin appearance and texture. Notably, patients with moderate-to-severe acne reaped substantial benefits and relief.
- Oiliness Control and Skin Quality Enhancement
- Visible Results: Users reported a noticeable decrease in skin oiliness. By week 12, a significant number achieved a ‘low/not oily’ skin status.
- Texture Transformation: Beyond acne clearance, the lotion enhances skin texture.
- Safety and Comfort
- Patient-Centric Approach: Safety matters. Fortunately, tazarotene 0.045% lotion is well-tolerated. Most adverse events were mild and transient, ensuring patient comfort throughout treatment.
Conclusion: A New Era in Skincare
Tazarotene 0.045% lotion represents a dual-action solution for individuals struggling with acne and oily skin. Not only does it effectively clear acne lesions, but it also enhances skin quality.
What's your take on this promising new lotion and how it can be used in the treatment of acne?
Share